Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Coumarin-based fluorescent probe for the rapid detection of peroxynitrite ‘AND’ biological thiols

Luling Wu *a, Xue Tiana, Robin R. Groleaua, Jie Wangb, Hai-Hao Hanb, Shaun B. Reekstingc, Adam C. Sedgwickd, Xiao-Peng Heb, Steven D. Bulla and Tony D. James*a
aDepartment of Chemistry, University of Bath, Bath, BA2 7AY, UK. E-mail: t.d.james@bath.ac.uk; lw960@bath.ac.uk
bKey Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Feringa Nobel Prize Scientist Joint Research Center, School of Chemistry and Molecular Engineering, East China University of Science and Technology, 130 Meilong Rd., Shanghai 200237, China
cMaterials and Chemical Characterization (MC2), University of Bath, Bath BA2 7AY, UK Web: https://doi.org/10.15125/mx6j-3r54
dDepartment of Chemistry, University of Texas at Austin, 105 E 24th Street A5300, Austin, TX 78712-1224, USA

Received 7th February 2020 , Accepted 13th March 2020

First published on 3rd April 2020


Abstract

A coumarin-based novel ‘AND’ logic fluorescent probe ROS-AHC has been developed for the simultaneous detection of ONOO and biological thiols. ROS-AHC was shown to exhibit only a very small fluorescence response upon addition of a single GSH or ONOO analyte. Exposure to both analytes, however, resulted in a significant fluorescence enhancement.


Peroxynitrite (ONOO) is a short-lived reactive oxygen and reactive nitrogen species (ROS and RNS) produced intracellularly by the diffusion-controlled reaction of nitric oxide (NO˙) with superoxide (O2˙).1–3 Despite playing a key role as a physiological regulator,4 it is commonly known for its high reactivity towards most types of biomolecules, causing deleterious effects and irreversible damage to proteins, nucleic acids, and cell membranes.5,6 ONOO is therefore a central biological pathogenic factor in a variety of health conditions such as strokes, reperfusion injuries or inflammatory and neurodegenerative diseases (Parkinson's disease, Alzheimer's disease).7–9 Conversely, biothiols such as glutathione and cysteine are endogenous reducing agents, playing a central role in the intracellular antioxidant defence systems.10–12 Glutathione (GSH), in particular, is the most abundant biothiol in mammalian cells, and exists as both its reduced GSH form, and as the oxidised disulphide form GSSG.13–15 Peroxynitrite and biothiols such as GSH are intimately linked, as abnormal levels of highly oxidising ONOO can perturb the delicate GSH/GSSG balance, causing irreversible damage to key processes such as mitochondrial respiration.16 Thus, abnormal levels of GSH are common in cells undergoing oxidative stress, in which the regulation of and interplay between ONOO and GSH is closely associated with physiological and pathological processes.17,18 One such example is drug-induced liver injury (DILI), in which upregulation of ONOO occurs in hepatotoxicity. Treatment with GSH could be used to remediate this type of cell injury by depletion of ONOO.19–22

One of our core research interests lies in the development of dual analyte chemosensors capable of detecting two distinct analytes such as biological reactive oxygen species and biothiols.23–26 Although a wide range of single-analyte probes exist for the detection of ROS and thiols separately,27–30 ‘AND’ logic sensors for their simultaneous detection are still rare.31–33 We are therefore interested in developing such probes, containing two distinct sensing units, one for each analyte, working simultaneously or in tandem to elicit a fluorescence response.34 This approach allows the monitoring of multiple biomolecular events and factors involved in specific disease pathologies, in order to achieve optimal predictive accuracy for diagnosis and prognostication.35

Using these principles, our group has recently focused on developing a range of ‘AND’ logic based sensors exploiting a variety of sensing units and mechanisms of fluorescence. Two such probes are shown below: GSH-ABAH (Fig. 1a), an ESIPT probe with a 4-amino-2-(benzo[d]thiazol-2-yl)phenol (ABAH) core, employing a maleic anhydride thiol-acceptor group;31 and JEG-CAB (Fig. 1b), a coumarin-based probe, this time with a salicylaldehyde homocysteine-reactive unit.24 Both of these sensors employ a benzyl boronate ester as their peroxynitrite-reactive unit.


image file: d0ra02234a-f1.tif
Fig. 1 (a) GSH-ABAH, previously reported probe for simultaneous detection of ONOO and GSH. (b) JEG-CAB, previously reported probe for simultaneous detection of ONOO and GSH. (c) AHC – a core fluorescent unit that enables the synthesis of ‘AND’ based fluorescent probe for the detection of ONOO and GSH (d) ROS-AHC, a novel probe detailed in this work for simultaneous detection of ONOO and GSH.

Herein, we set out to develop an ‘AND’ logic gate based fluorescence probe for simultaneous detection of ONOO and GSH. 3-Amino-7-hydroxy-2H-chromen-2-one (AHC) was chosen as a suitable coumarin fluorophore core for the development of an ‘AND’ logic based sensor, as its free phenol and amine functional groups provided a good opportunity for independent derivatization (Fig. 1).36–39

Previous literature reports show that protection of AHC with a maleic anhydride group results in quenching of the coumarin's fluorescence intensity due to photoinduced electron transfer (PeT) processes. This fluorescence is rapidly restored in the presence of biological thiols, however, due to their fast addition to this functional group.40 Therefore, we suggested that functionalization of the free phenol of this sensor using a benzyl boronic ester should further block the fluorescence, whilst serving as reporter unit for ONOO. The greatly increased reactivity of peroxynitrite over other ROS towards boronate esters41–43 should allow this functionality to act as a peroxynitrite-selective reporter, leading to an ‘AND’ logic based probe for the detection of ONOO and biological thiols (Fig. 1, Scheme 1). ROS-AHC was synthesized in 5 steps, starting with a 4-step synthesis of compound 1 adapted from literature procedures,40,44 followed by the addition of the benzyl boronic pinacol ester (see Scheme S1 ESI).


image file: d0ra02234a-s1.tif
Scheme 1 Fluorescence ‘turn on’ mechanism of ROS-AHC in the presence of ONOO and GSH.

The UV-Vis behaviour of ROS-AHC before and after exposure to both GSH and ONOO was evaluated in pH 7.40 buffer solution, showing a maximum absorption peak at 340 nm for both the unreacted probe and the probe following exposure to GSH, shifting to 350 nm with the addition of ONOO to the probe and 365 nm after sequential additions of GSH and ONOO to the probe (Fig. S1 ESI). Fluorescence experiments were then carried out. As expected, ROS-AHC was initially non-fluorescent, with a small fluorescence increase upon addition of ONOO (6 µM) (Fig. 2 and S2 ESI). Incremental additions of GSH (0–4.5 µM) resulted in a much larger increase in fluorescence intensity (>69-fold, see Fig. 2 and S3 ESI), demonstrating the need for both GSH and ONOO in order to achieve a significant ‘turn on’ fluorescence response.


image file: d0ra02234a-f2.tif
Fig. 2 Fluorescence spectra of ROS-AHC (5 µM) with addition of ONOO (6 µM), wait 5 min then incremental addition of GSH (0–4.5 µM), 5 min incubation before measurements in PBS buffer solution (10 mM, pH = 7.40). Fluorescence intensities were measured with λex = 400 nm (bandwidth 8 nm). The green line represents the highest intensity after addition of GSH (4 µM).

Similar fluorescence experiments were then carried out in reverse order, with the addition of GSH (6 µM) to ROS-AHC resulting in only a small increase in fluorescence intensity (Fig. 3 and S4 ESI). As before, incremental addition of the second analyte, in this case ONOO (0–5.5 µM), resulted in a large increase in fluorescence intensity (>46-fold, Fig. 3 and S5 ESI), confirming that ROS-AHC requires both GSH and ONOO for a full fluorescence ‘turn on’ response.


image file: d0ra02234a-f3.tif
Fig. 3 Fluorescence spectra of ROS-AHC (5 µM) with addition of GSH (6 µM), wait 5 min then incremental addition of ONOO (0–5.5 µM) with 5 min incubation before measurements in PBS buffer solution (10 mM, pH = 7.40). Fluorescence intensities were measured with λex = 400 nm (bandwidth 8 nm). The orange line shows the highest intensity after addition of ONOO (5 µM).

Subsequently, the selectivity of this probe towards both analytes was evaluated. A range of amino acids were evaluated (Fig. S6 ESI), with only thiol-containing analytes (glutathione, cysteine and homocysteine) eliciting significant fluorescence response, whilst non-thiol amino acids led to no changes in fluorescence intensity. A broad screen of ROS analytes was also carried out, demonstrating excellent selectivity for ONOO, even over H2O2 (Fig. S7 ESI).

The time-dependent response of ROS-AHC with both ONOO and GSH was also examined (Fig. S8 and S9 ESI). After initial addition of GSH or ONOO to the probe, subsequent addition of the second analyte triggered a rapid and significant increase in fluorescence, achieving maximum fluorescence intensity within 78 s in both cases. Furthermore, LC-MS experiments confirmed the formation of the suggested non-fluorescent intermediates, as well as the final fluorescent species shown in Scheme 1 (Fig S10, S11 and S12).

In summary, we have developed a coumarin-based dual-analyte ‘AND’ logic fluorescent sensor, ROS-AHC, for the simultaneous detection of ONOO and biological thiols. ROS-AHC has shown high sensitivity and selectivity towards both ONOO and biological thiols.

Conflicts of interest

No conflicts of interest.

Acknowledgements

LW wishes to thank China Scholarship Council and the University of Bath for supporting his PhD work in the UK. We would like to thank the EPSRC and the University of Bath for funding. X.-P. He thanks the National Natural Science Foundation of China (21722801, 21788102 and 91853201). RRG wishes to thank the EPSRC Centre for Doctoral Training in Catalysis for funding and support (EP/L016443/1). TDJ wishes to thank the Royal Society for a Wolfson Research Merit Award. NMR characterisation facilities were provided through the Materials and Chemical Characterisation Facility (MC2) at the University of Bath (www.bath.ac.uk/research-facilities/material-and-chemical-characterisation-facility-mc2). The EPSRC UK National Mass Spectrometry Facility at Swansea University is thanked for analyses. All data supporting this study are provided as ESI accompanying this paper.

Notes and references

  1. C. Szabó, H. Ischiropoulos and R. Radi, Nat. Rev. Drug Discovery, 2007, 6, 662–680 CrossRef PubMed.
  2. P. Pacher, J. S. Beckman and L. Liaudet, Physiol. Rev., 2007, 87, 315–424 CrossRef CAS PubMed.
  3. M. Trujillo and R. Radi, Arch. Biochem. Biophys., 2002, 397, 91–98 CrossRef CAS PubMed.
  4. P. Ferdinandy, Br. J. Pharmacol., 2006, 148, 1–3 CrossRef CAS PubMed.
  5. G. Storz and J. A. Imlayt, Curr. Opin. Microbiol., 1999, 2, 188–194 CrossRef CAS PubMed.
  6. P. Ascenzi, A. di Masi, C. Sciorati and E. Clementi, BioFactors, 2010, 36, 264–273 CrossRef CAS.
  7. P. Sarchielli, F. Galli, A. Floridi, A. Floridi and V. Gallai, Amino Acids, 2003, 25, 427–436 CrossRef CAS PubMed.
  8. H. Ischiropoulos and J. S. Beckman, J. Clin. Invest., 2003, 111, 163–169 CrossRef CAS.
  9. D. A. Wink, Y. Vodovotz, J. Laval, F. Laval, M. W. Dewhirst and J. B. Mitchell, Carcinogenesis, 1998, 19, 711–721 CrossRef CAS PubMed.
  10. J. S. Stamler and A. Slivka, Nutr. Rev., 1996, 54, 1–30 CAS.
  11. S. Iwata, T. Hori, N. Sato, Y. Ueda-Taniguchi, T. Yamabe, H. Nakamura, H. Masutani and J. Yodoi, J. Immunol., 1994, 152, 5633–5642 CAS.
  12. H. Nakamura, K. Nakamura and J. Yodoi, Annu. Rev. Immunol., 1997, 15, 351–369 CrossRef CAS.
  13. R. Dringen, J. M. Gutterer and J. Hirrlinger, Eur. J. Biochem., 2000, 267, 4912–4916 CrossRef CAS PubMed.
  14. B. Morgan, D. Ezeriņa, T. N. E. Amoako, J. Riemer, M. Seedorf and T. P. Dick, Nat. Chem. Biol., 2013, 9, 119–125 CrossRef CAS PubMed.
  15. C. S. Lim, G. Masanta, H. J. Kim, J. H. Han, H. M. Kim and B. R. Cho, J. Am. Chem. Soc., 2011, 133, 11132–11135 CrossRef CAS PubMed.
  16. L. Virág, É. Szabó, P. Gergely and C. Szabó, Toxicol. Lett., 2003, 140–141, 113–124 CrossRef.
  17. K.-A. Marshall, M. Reist, P. Jenner and B. Halliwell, Free Radical Biol. Med., 1999, 27, 515–520 CrossRef CAS PubMed.
  18. J. P. Bolaños, S. J. R. Heales, J. M. Land and J. B. Clark, J. Neurochem., 1995, 64, 1965–1972 CrossRef PubMed.
  19. A. J. Shuhendler, K. Pu, L. Cui, J. P. Uetrecht and J. Rao, Nat. Biotechnol., 2014, 32, 373–380 CrossRef CAS PubMed.
  20. D. Li, S. Wang, Z. Lei, C. Sun, A. M. El-Toni, M. S. Alhoshan, Y. Fan and F. Zhang, Anal. Chem., 2019, 91, 4771–4779 CrossRef CAS PubMed.
  21. W.-L. Jiang, Y. Li, W.-X. Wang, Y.-T. Zhao, J. Fei and C.-Y. Li, Chem. Commun., 2019, 55, 14307–14310 RSC.
  22. G. S. Kelly, Altern. Med. Rev., 1998, 3, 114–127 CAS.
  23. L. Wu, A. C. Sedgwick, X. Sun, S. D. Bull, X.-P. He and T. D. James, Acc. Chem. Res., 2019, 52, 2582–2597 CrossRef CAS PubMed.
  24. L. Wu, J. E. Gardiner, L. K. Kumawat, H.-H. Han, R. Guo, X. Li, X.-P. He, R. B. P. Elmes, A. C. Sedgwick, S. D. Bull and T. D. James, RSC Adv., 2019, 9, 26425–26428 RSC.
  25. L. Wu, L. Liu, H.-H. Han, X. Tian, M. L. Odyniec, L. Feng, A. C. Sedgwick, X.-P. He, S. D. Bull and T. D. James, New J. Chem., 2019, 43, 2875–2877 RSC.
  26. M. Weber, A. B. Mackenzie, S. D. Bull and T. D. James, Anal. Chem., 2018, 90, 10621–10627 CrossRef CAS PubMed.
  27. A. C. Sedgwick, J. E. Gardiner, G. Kim, M. Yevglevskis, M. D. Lloyd, A. T. A. Jenkins, S. D. Bull, J. Yoon and T. D. James, Chem. Commun., 2018, 54, 4786–4789 RSC.
  28. L. Wu, Q. Yang, L. Liu, A. C. Sedgwick, A. J. Cresswell, S. D. Bull, C. Huang and T. D. James, Chem. Commun., 2018, 54, 8522–8525 RSC.
  29. M. L. Odyniec, H.-H. Han, J. E. Gardiner, A. C. Sedgwick, X.-P. He, S. D. Bull and T. D. James, Front. Chem., 2019, 7, 775 CrossRef PubMed.
  30. L. Wu, Y. Wang, M. Weber, L. Liu, A. C. Sedgwick, S. D. Bull, C. Huang and T. D. James, Chem. Commun., 2018, 54, 9953–9956 RSC.
  31. L. Wu, H.-H. Han, L. Liu, J. E. Gardiner, A. C. Sedgwick, C. Huang, S. D. Bull, X.-P. He and T. D. James, Chem. Commun., 2018, 54, 11336–11339 RSC.
  32. A. C. Sedgwick, H.-H. Han, J. E. Gardiner, S. D. Bull, X.-P. He and T. D. James, Chem. Sci., 2018, 9, 3672–3676 RSC.
  33. F. Yu, P. Li, G. Li, G. Zhao, T. Chu and K. Han, J. Am. Chem. Soc., 2011, 133, 11030–11033 CrossRef CAS PubMed.
  34. J. L. Kolanowski, F. Liu and E. J. New, Chem. Soc. Rev., 2018, 47, 195–208 RSC.
  35. A. Romieu, Org. Biomol. Chem., 2015, 13, 1294–1306 RSC.
  36. H. Zhang, C. Zhang, R. Liu, L. Yi and H. Sun, Chem. Commun., 2015, 51, 2029–2032 RSC.
  37. C. Y. Ang, S. Y. Tan, Y. Lu, L. Bai, M. Li, P. Li, Q. Zhang, S. T. Selvan and Y. Zhao, Sci. Rep., 2014, 4, 7057 CrossRef CAS PubMed.
  38. O. García-Beltrán, B. K. Cassels, C. Pérez, N. Mena, M. T. Núñez, N. P. Martínez, P. Pavez and M. E. Aliaga, Sensors, 2014, 14, 1358–1371 CrossRef PubMed.
  39. C. Nicosia, J. Cabanas-Danés, P. Jonkheijm and J. Huskens, ChemBioChem, 2012, 13, 778–782 CrossRef CAS PubMed.
  40. L. Yi, H. Li, L. Sun, L. Liu, C. Zhang and Z. Xi, Angew. Chem., Int. Ed., 2009, 48, 4034–4037 CrossRef CAS PubMed.
  41. S. Palanisamy, P.-Y. Wu, S.-C. Wu, Y.-J. Chen, S.-C. Tzou, C.-H. Wang, C.-Y. Chen and Y.-M. Wang, Biosens. Bioelectron., 2017, 91, 849–856 CrossRef CAS PubMed.
  42. X. Sun, Q. Xu, G. Kim, S. E. Flower, J. P. Lowe, J. Yoon, J. S. Fossey, X. Qian, S. D. Bull and T. D. James, Chem. Sci., 2014, 5, 3368–3373 RSC.
  43. A. Sikora, J. Zielonka, M. Lopez, J. Joseph and B. Kalyanaraman, Free Radical Biol. Med., 2009, 47, 1401–1407 CrossRef CAS PubMed.
  44. J. Jiang, C. Gou, J. Luo, C. Yi and X. Liu, Inorg. Chem. Commun., 2012, 15, 12–15 CrossRef CAS.

Footnotes

Electronic supplementary information (ESI) available. See DOI: 10.1039/d0ra02234a
Equal contribution.

This journal is © The Royal Society of Chemistry 2020